October 22, 2014, Stephen Marmaras on behalf of GHLF, provided testimony in opposition of Idaho’s Board of Pharmacy rule that does not satisfy the safety needs required for state biosimilar substitution
GHLF Idaho Board of Pharmacy Proposed Rule Testimony 10-22-14